Literature DB >> 24293217

Nonmicrobial-mediated inflammatory airway diseases--an update.

Polani B Ramesh Babu1, P Krishnamoorthy.   

Abstract

In lungs, airways are in constant contact with air, microbes, allergens, and environmental pollutants. The airway epithelium represents the first line of lung defense through different mechanisms, which facilitate clearance of inhaled pathogens and environmental particles while minimizing an inflammatory response. The innate immune system facilitates immediate recognition of both foreign pathogens and tissue damage through toll-like receptor, which acts as a gateway for all intracellular events leading to inflammation. In the absence of microbial stimulus, the immune system is capable of detecting a wide range of insults against the host. This review focuses on various molecular mechanisms involved in pathophysiology of airway inflammation mediated by environmental factors, cellular stress, and pharmacological and clinical agents.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24293217     DOI: 10.1007/s13105-013-0297-9

Source DB:  PubMed          Journal:  J Physiol Biochem        ISSN: 1138-7548            Impact factor:   4.158


  83 in total

Review 1.  The effect of environmental oxidative stress on airway inflammation.

Authors:  Amy Auerbach; Michelle L Hernandez
Journal:  Curr Opin Allergy Clin Immunol       Date:  2012-04

Review 2.  Biology of lung dendritic cells at the origin of asthma.

Authors:  Bart N Lambrecht; Hamida Hammad
Journal:  Immunity       Date:  2009-09-18       Impact factor: 31.745

3.  A role for mitochondria in NLRP3 inflammasome activation.

Authors:  Rongbin Zhou; Amir S Yazdi; Philippe Menu; Jürg Tschopp
Journal:  Nature       Date:  2010-12-01       Impact factor: 49.962

4.  Amino-functionalized polystyrene nanoparticles activate the NLRP3 inflammasome in human macrophages.

Authors:  Oleg Lunov; Tatiana Syrovets; Cornelia Loos; G Ulrich Nienhaus; Volker Mailänder; Katharina Landfester; Mustapha Rouis; Thomas Simmet
Journal:  ACS Nano       Date:  2011-12-08       Impact factor: 15.881

Review 5.  Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary.

Authors:  R A Pauwels; A S Buist; P M Calverley; C R Jenkins; S S Hurd
Journal:  Am J Respir Crit Care Med       Date:  2001-04       Impact factor: 21.405

Review 6.  Management of phosgene-induced acute lung injury.

Authors:  Christopher Grainge; Paul Rice
Journal:  Clin Toxicol (Phila)       Date:  2010-07       Impact factor: 4.467

7.  The role of acetaminophen and geohelminth infection on the incidence of wheeze and eczema: a longitudinal birth-cohort study.

Authors:  Alemayehu Amberbir; Girmay Medhin; Atalay Alem; John Britton; Gail Davey; Andrea Venn
Journal:  Am J Respir Crit Care Med       Date:  2010-10-08       Impact factor: 21.405

Review 8.  New mechanisms of pulmonary fibrosis.

Authors:  Robert M Strieter; Borna Mehrad
Journal:  Chest       Date:  2009-11       Impact factor: 9.410

Review 9.  From endoplasmic-reticulum stress to the inflammatory response.

Authors:  Kezhong Zhang; Randal J Kaufman
Journal:  Nature       Date:  2008-07-24       Impact factor: 49.962

Review 10.  Pathogenesis of chronic obstructive pulmonary disease.

Authors:  Rubin M Tuder; Irina Petrache
Journal:  J Clin Invest       Date:  2012-08-01       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.